(Q43975771)

28 November 2017

title

Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome (English)

1 reference

28 November 2017

0 references

Jeffrey L Rausch

1

1 reference

28 November 2017

Maria E Johnson

2

1 reference

28 November 2017

You-Jun Fei

3

1 reference

28 November 2017

Jun Qing Li

4

1 reference

28 November 2017

Nitin Shendarkar

5

1 reference

28 November 2017

Henry Mac Hobby

6

1 reference

28 November 2017

Vadivel Ganapathy

7

1 reference

28 November 2017

Fred H Leibach

8

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

28 November 2017

published in

Biological Psychiatry

1 reference

28 November 2017

volume

51

1 reference

28 November 2017

issue

9

1 reference

28 November 2017

page(s)

723-732

1 reference

Autosomal recessive inheritance of affective disorders in families of responders to lithium prophylaxis?

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

Stress-induced changes of extracellular 5-hydroxyindoleacetic acid concentrations followed in the nucleus raphe dorsalis and the frontal cortex of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

Predictive value of two endogenicity measures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

A molecular and cellular theory of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

Clinical predictors of response to antidepressants in elderly patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

Prediction of response to nortriptyline and phenelzine by platelet MAO activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

Allelic Variation of Human Serotonin Transporter Gene Expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

Predictors of drug response in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

Fluoxetine in patients with major depressive disorder--a responder analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

Organization of the human serotonin transporter gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

Effect of antidepressant treatment on platelet 5-HT content and relation to therapeutic outcome in unipolar depressive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

Predictors of hospital outcome without antidepressants in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

Pharmacogenetic response to antidepressants in a multicase family with affective disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

Differentiation of two genetically specific types of depression by the response to anti-depressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

Construction of human gene libraries from small amounts of peripheral blood: analysis of beta-like globin genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

Biosynthesis, N-glycosylation, and surface trafficking of biogenic amine transporter proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

An hypothesis of initial conditions: receptor-effector systems as determinants of psychopharmacologic drug response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

Fluvoxamine treatment of mixed anxiety and depression: evidence for serotonergically mediated anxiolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

Biological predictors of antidepressant treatment outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Antidepressants, metabolites, and apparent drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901283-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(01)01283-5

1 reference

28 November 2017

1 reference